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1. Introduction
Infective endocarditis (IE) is an endovascular infection and inflammation with vegetation
formation, usually caused by infectious agents. Bacterial infection is most common for IE, but
other pathogens such as fungi, richettsia, chlamydia and virus, can also cause IE [1]. The
vegetations vary in size and shape and are composed of platelet and fibrin blocks with plenty
of microbial and small amounts of inflammatory cells inside [2]. IE occurs mostly in the patients
with cardiac abnormalities or lesions including rheumatic heart disease, ventricular septal
defect, patent ductus arteriosus, valvular stenosis or incompetence [3]. Nevertheless, IE can
also be seen in other conditions, such as valve replacement, pacemaker implantation, intrave‐
nous drug users and a few people without cardiac lesions. Most patients are young and
clinically exhibit low to mild fever, progressive anemia, asthenia, night sweat, hepatospleno‐
megaly and clubbed finger (toe) [1-3].
The incidence of IE is 30 per million persons per year [4]. Despite major improvements in diagnosis
and treatment, the mortality of IE still remains high at 14% of in-hospital and even higher at 20%
to 30% complicated with age and heart failure, especially in developing countries [5,6]. Based
on different criteria, IE can be divided by several classifications. By duration, IE can be classi‐
fied to subacute bacterial endocarditis (SBE) and acute bacterial endocarditis (ABE); By culture
result, IE can be divided by staphylococcal endocarditis, streptococcal endocarditis, enterococcal
endocarditis, fungal endocarditis; By individual valve type, IE can be classified by native valve
endocarditis, prosthetic valve endocarditis and endocarditis in intravenous drug abusers [2-4].
As reported in a study with an IE population of 223 episodes, complications occurred in 74%
patients, including cardiac, neurological, septic, renal, embolism and infarction/ abscess [7]. It
also suggests that neurologic and septic complications are the leading causes of death in IE
patients [7]. With the improvement of diagnosis and therapy, the frequencies of IE complica‐
tions have changed. For example, septic and embolic symptoms are relatively rare because of
early and adequate dosage of antibiotic therapy [4]. On the contrary, there are increasing
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complications in prosthetic valve IE and intravenous drug abuse patients which may bring new
challenge for clinical diagnosis and therapy. Since there are different diagnostic criteria for IE,
it is difficult to conclude the true incidence of IE [8]. Overall, diagnosis is missed until autopsy
in 38.2% of cases, especially when the patients are absence of fever, cardiac murmurs and other
typical symptoms of IE [9]. In this chapter, several most common complications and related
pathophysiologic process in IE patients will be summarized.
2. Intracardiac infection and local spread
Cardiac complications are the most common complications seen in IE patients, occurring in
one-third to one-half of patients in most recent case series [10, 11].
2.1. Congestive Heart Failure (CHF)
CHF is a leading cause of death in IE patients [12]. The size of nodular or polypoid-like
vegetation varies from 1 micrometer to several centimeters which can block the valve entrance
[13]. The vegetation can cause valvular perforation and lead to prolapse. When the infection
is controlled, valve lesions may still go on with fibrosis and contracture in some cases. All of
these pathologic changes induce valvular insufficiency, mainly involved in aortic valve (50%),
mitral valve (40%) and tricuspid valve (6%) [14]. A study on 511 IE patients show that moderate
or severe congestive heart failure accounts for 44% in total complications [15]. According the
report enrolling 4166 IE patients from multi centers in 28 countries, 33.4% patients have heart
failure and 66.7% of the heart failure patients are classified as New York Heart Association
class III or IV symptom status [16]. The total in-hospital mortality is 29.7% for the CHF cohort.
They conclude that the severities of CHF in IE patients are associated with surgical status and
mortality [16]. Based on the seriousness of CHF in the course of IE patients, the timing for early
prophylaxis and treatment will influence its prognostic significance.
2.2. Cardiac abscess
Abscess is most common in acute patients and may happen anywhere in the heart [17]. The
most frequent cardiac abscess occurs in aortic root of 56.5% of (26/46) IE patients, and the
infecting organism is staphylococcus (52.3%) in patients with abscesses more often than in
those without abscesses (16.2%) [17]. Occasionally, cardiac abscess can cause papillary muscle
rupture, ventricular septal perforation, and even purulent pericarditis when the infection
infiltrates the myocardial wall [13]. Moreover, the infection beyond the valve annulus can
spread to adjacent structures and cause an emergency and higher mortality which can be
observed in 88% of cases [18]. Another study on a large number of cases with valvular ring
abscesses suggests that early identification of abscesses is particularly important to improve
the outcome after timely surgery [19]. They also conclude that the overall operative mortality
is not correlated with patient’s age, staphylococcal infection or abscess fistulization [19].
However, the diagnosis is difficult, especially for small abscesses located on the anterior aortic
wall and mitral abscesses.
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3. Embolic
Embolization is frequently observed in IE patients and can even occur in patients undergo‐
ing therapies. IE patients have high prevalence of embolic complications for 13-49% [20]. In
a study of 65 IE patients, a total of 37 (56.9%) patients are diagnosed with a cerebral embolism
(overt 13, clinically silent 24) by blood test, cultures, echocardiography, and MRI/CT imaging
[21]. Their results suggest that both overt and clinical silent central nervous system embolism
are common complications of IE patients and silent embolism needs further imaging tools
for examination [21]. Recently, their group uses some new biological markers, such as S-100B,
to predict embolism in central nervous system during the course of IE [22]. Since most of
the S-100B protein are synthesized by astrocytes and released from damaged neural tissues,
the biomarker provides another specific method for screening CNS stroke in IE patients. An
early  study shows that  the  microorganism,  but  not  vegetations  on echocardiography,  is
associated with a significantly higher risk for embolus in patients with left-sided IE [23].
With transthoracic echocardiography in predicting embolic events, another group found that
the vegetations bigger than 10 mm were associated with a 50% incidence of embolic events,
while  vegetations  less  than  10  mm  had  a  42%  incidence  of  emboli  in  IE  patients  [24].
Similarly,  in  the  patients  who  are  diagnosed  with  acute  IE  and  have  no  confirmed  or
suspected embolism before, 44% (25 in 57) have embolic events by using both transthora‐
cic  and  transesophageal  echocardiograms  [25].  They  also  suggest  the  characteristics  of
vegetations identified by echocardiograms are not helpful in predicting embolic risk in IE
patients [25]. In combination with clinical antibiotic therapy, embolism occurred in 34.1%
(131 in 384) patients before/after IE diagnosis and in 7.3% (28 in 384) patients after initia‐
tion of therapy [26].
Besides neurological embolism, other organs such as spleen, kidney, lung and limbs, are also
involved in rare cases [27, 28]. According to a report by Luaces-Méndez et al, there are 10%
hepatosplenic and renal embolisms infarctions in left-sided IE patients with characteristic
clinical features [29]. But in fungi caused IE, emboli occurs in 25%(41 in 162) patients and
symptomatic embolization appears to be more common of 17% (7 in 41) in peripheral limb,
7% (3 in 41) in pulmonary, 5% (2 in 41) in mesenteric [30].
The characteristics of bacterial embolus are multiple, fragile and movable, so in many cases IE
patients present with stroke, meningitis, brain abscess and bacterial aneurysm.
3.1. Stroke
Ischemic and hemorrhagic strokes are important neurological complications and are frequent
in IE patients during uncontrolled infection. There are about 21% complicated by stroke in 212
IE patients in a study between 1978 and 1986 [31]. In a population of 214 IE patients undergoing
cardiac surgery, the prognosis for patients with uncomplicated ischemic stroke are better than
patients with complicated stroke (meningitis, hemorrhage, or brain abscess) after 20 years
following up [32]. In order to prevent cardioembolic stroke, additional diagnostic tools such
as echocardiography and cardiac magnetic resonance imaging, can be applied to identify the
sources of cardiac embolism. Another investigation in 707 patients who are diagnosed with
Complications of Endocarditis
http://dx.doi.org/10.5772/56091
3
possible IE, strokes occur in 9.6% of total cases, which is lower than previous reports (21 to
39%) [33]. In order to study the relationship between vegetation 2-dimensional size and stroke
in those IE patients, researchers use Duke Endocarditis Database to examine 145 IE patients
and find 23.4% (34 in 145) complicated by stroke, suggesting vegetation 2-dimensional size
and characteristics as predictors for stroke and mortality [34].
3.2. Mycotic aneurysm
If the artery is blocked by the septic embolus, the wall may be necrosised and destroyed, and
then develop bacterial aneurysm. Mycotic aneurysm is rare, about 4% (23 in 513), in IE patients
[15]. Aorta, brain, viscera and limbs can become involved in turn [35]. Patients can show
throbbing lump during the late stage. The disease is easily diagnosed while occuring at
peripheral vessels. However, when the lesion happens in deep arteries such as brain and
mesentery, aneurysm is always ignored until it is broken and bleeding [36]. Mycotic aneurysm
has a high mortality rate for its potential catastrophic rupture but can be prevented by early
diagnostic imaging techniques [37]. Cerebral mycotic aneurysms tend to occur in the more
distal portions of the middle cerebral artery, especially in the region of the sylvian fissure,
which clinically is different from berry aneurysms occurring near the Willis circle [38].
3.3. Cerebral hemorrhage
Cerebral hemorrhage will occur when the vessel is broken in bacterial aneurysm or embolism.
It is easy to develop spotted or patched hemorrhage when there is big area of infarction in the
brain. There are three different mechanisms for cerebral haemorrhage in IE patients: rupture
of a mycotic aneurysm, septic arteritis without aneurysm, spontaneous haemorrhagic trans‐
formation of a blank brain infarction [39].
Subarachnoid hemorrhage is a rare but dramatic neurologic complication in IE patients and
is always associated with aneurysm rupture in the early phase [40]. Previous reports show that
high mortality is related to intracerebral haemorrhage [41, 42]. The species of microorganism
seem to have relationship with brain haemorrhage. Data presented in an investigation shows
that brain haemorrhages in 40.7% (35 in 86) IE patients are caused by Staphylococcus aures [43].
4. Hematogenous dissemination
4.1. Metastatic abscess
When the vegetation with infecting bacteria drops off, it will migrate with blood and cause
embolism in the artery. During a report on 118 IE patients, 44 (37.3 %) patients have 46 definite
regions of abscess in total and abscesses present more frequently in endocarditis from aortic-
valve than other valves [17]. If the infection is not controlled well, abscesses can develop in the
spleen, kidney, brain or soft tissues in IE patients. With the improvement of antibiotic treat‐
ment, metastatic abscess is relatively rare but still reported in recent years [44-46].
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Splenic abscesses are found in up to 5% IE patients and usually exhibit abdominal pain,
pleuritic or shoulder pain as of diaphragmatic irritation, or persistent fever [47]. According to
the conclusion from 27 patients with splenic abscess, the cases could not survive without a
timely splenectomy surgery [48]. If possible, the patient with IE should be treated first for
splenic abscesses and then splenectomy should be performed for the requirements.[49].
Cerebral abscess is rare in IE patients including suppurative encephalitis, chronic granuloma
and abscess envelope [50]. The time for envelope formation depends on the types of bacteria
and the toxicity, body’s resistance and reaction for antibiotic therapy [51]. According to the
report on a series of cases, miliary microscopic abscesses are more common than macroscopic
cerebral abscess in bacterial endocarditis patients, particularly in patients with acute miliary
infection [41]. Cerebral abscesses in some IE patients are suggested to be related with S.
aureus infection and purulent meningitis [41].
4.2. Toxic encephalopathy
Toxic encephalopathy occurs when plenty of bacteria enter the circulation and cause septice‐
mia. In an investigation of 110 patients, 19.1% (21 in 110) show toxic encephalopathy, which
is ranked the second common neurological manifestation of IE patients [52]. Frequently, the
patients display a variety of symptoms, such as early stage of headache, dizziness, hypersom‐
nia, nausea, vomit and late stage of hallucination, memory loss, small personality changes,
seizures, disturbance of consciousness. The multiple cerebral emboli and multifocal microin‐
farcts cause formation of microabscesses, which may explain the pathophysiological mecha‐
nism for acute encephalopathy [53].
4.3. Purulent meningitis
This complication is uncommon and concomitant with cerebral abscess. Sometimes the
intracerebral abscess may enter subarachnoid cavity and cerebral ventricle to invade mening‐
es, which will cause purulent meningitis [54]. If Streptococcus anaerobius, bacteroid, Staphylococ‐
cus and mixed bacteria are separated in cerebrospinal fluid, it suggests that there are
relationships between meningitis and broken intracerebral abscess.
5. Musculoskeletal complications
The musculoskeletal manifestations include spondylodiscitis, osteomyelitis, septic arthritis
and peripheral soft tissue abscess, which occur frequently in up to 44% cases [55]. Because the
existing of osteoarticular complications, the patients are at a higher risk of having major
embolic events from the central nerve system to lungs [56]. Vertebral osteomyelitis is relatively
rare complication in IE patients. Overall, 4.6% (28 in 606) cases in IE patients have pyegenic
vertebral osteomyelitis [57]. The patients are needed to exclude IE if they have spondylodiscitis
and pre-existing heart disease or microbiologic infection [58]. With MRI as a highly sensitive
and specific tool for diagnosing, patients with spondylodiscitis usually can be found early
before infection has spread to two vertebral body levels.
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In IE patients, the percentages of osteomyelitis and septic arthritis are up to 4.3%, and they
occur more frequently in patients with tricuspid valve involvement [56]. S. aureus are reported
to have higher frequencies than other microorganisms for causing osteomyelitis complication
in IE patients [59]. The infections usually occur at large joints and involve one or more joints,
including the knee, shoulder, elbow, hip and sacroiliac joints [56]. If the patients are infected
with multiple joints but don’t have joint infection or trauma, they are suspicious for septic
arthritis with IE.
6. Immune-mediated damage
With persistent bacteremia existing in IE patients, clinical manifestations, such as splenome‐
galy, glomerulonephritis and arthritis, may present because of cellular and humoral-mediated
immune response [60]. Patients with splenomegaly occur in 20% of cases and are more likely
in patients who have been ill for months rather than for days or weeks. Glomerulonephritis
are most common in S. aureus caused ABE and S. viridans caused SBE with histologic immune
deposits in the glomerular capillary wall [61]. With antibiotic prophylaxis and therapy in IE
patients, the incidence of glomerulonephritis decreases to about 4.5% (9 in 198) in an investi‐
gation [62]. Under rare conditions, patients with glomerulonephritis will develop diffuse
proliferative glomerulonephritis and extensive crescent formation with renal failure [63].
Other clinical manifestations, such as arthritis, pericarditis and micro-vessel vasculitis are also
found in IE patients. Vasculitis may cause unspecific signs on skin and mucosa, including
subconjunctival and soft palate petechiae, hemorrhages within the nail beds (splinter hemor‐
rhages), oval retinal bleeding spots with white center (Roth spots), painful subcutaneous
nodules on the palms or soles (Osler's nodes), painless bleeding spots on the palms and soles
with diameter of 1 to 4 mm (Janeway lesions) [1]. The pathogenesis for above lesions may be
caused by microemboli and microabscesses in the small vessels of dermis.
In summary, multidisciplinary approaches including clinician microbiologists, radiology,
cardiology and surgery are necessary for treatment of IE with complications. In order to get
better understanding, the complications are classified into several categories although some
features are overlapping or broad. For example, the IE patients with embolic complication can
have metastatic abscess, mycotic aneurysm or cerebral hemorrhage; patients with hematoge‐
nous dissemination can simultaneously have embolic and musculoskeletal symptoms. This
content tries to describe the frequency of IE complications and may help for better prophylaxis
and therapy.
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